The Investigation of Drug Resistance Substitutions in NS3 Protease Sequence of Hepatitis C Virus from Non-Responder Patients

BACKGROUND: Even with the fantastic successes of direct-acting antivirals (DAA) in the treatment of Hepatitis C Virus (HCV) infection, natural drug resistance remains a challenging obstacle for their impacts. The data regarding protease inhibitors (PIs) resistance in Iran population are limited. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Nejabat, Nargess, Hosseini, Seyed Younes, Sarvari, Jamal, Gorzin, Ali Akbar, Fattahi, Mohammad Reza, Rasoolian, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852801/
https://www.ncbi.nlm.nih.gov/pubmed/31450900
http://dx.doi.org/10.31557/APJCP.2019.20.8.2311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852801/
https://www.ncbi.nlm.nih.gov/pubmed/31450900
http://dx.doi.org/10.31557/APJCP.2019.20.8.2311

Ejemplares similares